September 30, 2024
IPWatchdog LIVE 2024
Join us for our Fourth Annual IPWatchdog LIVE Conference Bringing together the intellectual property community – from politicos, to business…
September 30, 2024
Gaithersburg’s Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
GAITHERSBURG, Md., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced completion of patient enrollment…
September 25, 2024
miRecule Showcases Innovative RNA Therapies this week at RESI Boston 2024
At RESI Boston 2024, held on September 25th at the Westin Copley Place, Montgomery County-based biotechnology company miRecule, a client…
September 25, 2024
NIH Awards Sonavex $2 Million Grant to Conduct Clinical Trial and Seek Regulatory Clearance of EchoGuide
EchoGuide is Sonavex’s pipeline product designed to improve cannulation for dialysis patients. Baltimore, MD (September 25th, 2024) – Sonavex, Inc.,…
September 25, 2024
Gaithersburg’s Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407
GAITHERSBURG, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first…
September 25, 2024
Maryland Governor Wes Moore Addresses BioHealth Capital Region Forum at USP
The BioHealth Capital Region Forum had the honor of hosting Maryland Governor Wes Moore, who addressed attendees at the 10th…
September 24, 2024
Fast Company: Johns Hopkins Technology Ventures proves you don’t need to move to a tech hub. Just build your own
The commercialization and technology transfer arm of the storied Baltimore university is helping to foster the region’s burgeoning tech scene.…